Vaccines & special-risk groups: Diabetes

FIP (International Pharmaceutical Federation) new series “Vaccines & special-risk groups” will discuss and highlight the risks that particular population groups are exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated. On 14 November, the series will focus in diabetes.

Moderator: Astrid Czock, CEO QualiCCare -Switzerland

  • Marco Goeijenbier, Medical doctor internal medicine and intensive care, Spaarne Gasthuis Haarlem/Hoofddorp & Erasmus Medical Center Rotterdam- The Netherlands
  • Sallianne Kavanagh, Senior Lecturer- Clinical Pharmacy and Pharmacy Practice. Advanced Clinical Pharmacist,  University of Huddersfield and Sheffield Teaching Hospitals NHSFT - United Kingdom
  • Iryna Vlasenko, Vice president International Diabetes Federation-Ukraine
  • Francisco Javier Jiménez Ramírez, Professor / Pharmacist University of Puerto Rico School of Pharmacy - Puerto Rico